Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05032625 · ClinicalTrials.gov registry record
To Evaluate the Outcomes After Surgery for Necrotizing Soft Tissue Infections
A clinical trial, sponsored by New York Medical College.
- Terminated
- Registry status
- 13
- Enrollment target
NCT05032625: Clinical Trial study, sponsored by New York Medical College.
NCT05032625 is a clinical trial that was terminated before completion, run by New York Medical College. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05032625 was terminated before completion, sponsored by New York Medical College.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
There is significant mortality associated with necrotizing soft tissue infections, it is imperative to decrease mortality and complications associated with this disease is determined. To accomplish this goal, study team will create a prospectively maintained database of all NSTI patients admitted at department of surgery. Investigators will asses the predictors of poor outcome and follow these patients for 1 year in clinic and asses the functional quality of life by incorporating 36-Item Short Form Survey (SF-36) score.
Primary Outcome
The short term objectives are to evaluate 30-day mortality.
Interventions
- PROCEDURE Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2020-09-01 |
Why NCT05032625 stopped before completion
NCT05032625 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Surgery is the first listed.
NCT05032625 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05032625 about?
NCT05032625 is a clinical study titled "To Evaluate the Outcomes After Surgery for Necrotizing Soft Tissue Infections". There is significant mortality associated with necrotizing soft tissue infections, it is imperative to decrease mortality and complications associated with this disease is determined. To accomplish this goal, study team will create a prospectively maintained database of all NSTI patients admitted at...
What is the current status of trial NCT05032625?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2019-07-01. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT05032625?
The interventions under investigation include: Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05032625?
This trial is sponsored by New York Medical College, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI